Epizyme Stock Price, News & Analysis
Company Description
Epizyme (NASDAQ: EPZM) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector. The company has a market capitalization of $247.5M.
EPZM stock has declined 73.2% over the past year.
This page provides a comprehensive overview of EPZM stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Epizyme (EPZM) stock. Over the past 12 months, the stock has lost 73.2%. At a market capitalization of $247.5M, EPZM is classified as a micro-cap stock with approximately 168.4M shares outstanding.
Latest News
Epizyme has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include earnings, acquisition, conferences. View all EPZM news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
EPZM Company Profile & Sector Positioning
Epizyme (EPZM) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.